Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Revenue, net $ 3,316 $ 2,506 $ 9,963 $ 6,876
Cost of revenue (excluding amortization of $970 and $986 for the three months and $2,909 and $2,825 for the nine months, respectively) 1,846 1,799 4,866 5,224
Gross profit 1,470 707 5,097 1,652
Operating expenses:        
Sales and marketing 1,282 2,876 4,186 8,387
Research and development 659 1,000 1,339 1,646
General and administrative 2,858 2,498 7,655 8,909
Acquisition related amortization expense 970 986 2,909 2,825
Asset impairment 3,363 3,363
Change in fair value of contingent consideration (1,174) (1,174)
Total operating expenses 7,958 7,360 18,278 21,767
Operating loss (6,488) (6,653) (13,181) (20,115)
Interest expense (539) (884) (1,601) (2,616)
Other income (expense), net 4 (112) 14 (268)
Loss from continuing operations before tax (7,023) (7,649) (14,768) (22,999)
Provision (benefit) for income taxes 173 (180) (54) (430)
Loss from continuing operations (7,196) (7,469) (14,714) (22,569)
(Loss) income from discontinued operations, net of tax (297) 2,574 101 6,828
Net loss (7,493) (4,895) (14,613) (15,741)
Net Loss and Comprehensive Loss $ (7,493) $ (4,895) $ (14,613) $ (15,741)
Basic and diluted (loss) income per share of common stock:        
From continuing operations (in dollars per share) $ (0.40) $ (0.48) $ (0.82) $ (1.48)
From discontinued operations (in dollars per share) (0.02) 0.16 0.01 0.45
Net loss per basic and diluted share of common stock (in dollars per share) $ (0.41) $ (0.31) $ (0.81) $ (1.03)
Weighted average number of common shares and common share equivalents outstanding:        
Basic weighted average number of of common shares (in shares) 18,163 15,654 18,029 15,301
Diluted (in shares) 18,163 15,654 18,029 15,301